ArisGlobal launches LifeSphere Regulatory platform

By Jenni Spinner contact

- Last updated on GMT

(ipopba/iStock via Getty Images Plus)
(ipopba/iStock via Getty Images Plus)

Related tags: Data management, Drug development, Software, Cloud software

The drug development software specialist has introduced technology designed to streamline regulatory information management.

ArisGlobal, a producer of software solutions geared toward automation of core drug development functions for global life sciences companies, has introduced LifeSphere Regulatory. The cloud-based platform is designed to help users handle their entire regulatory management process in one integrated suite.

The platform consists of two key parts. The LifeSphere RIMS component is engineered to manage core regulatory processes. LifeSphere Publishing is a submissions management system that reportedly lets  life-science organizations compile, publish, and validate regulatory submissions with support for all major global eCTD requirements.

The LifeSphere Regulatory platform also is integrated with LifeSphere EasyDocs, a cloud document management platform that provides a single source of reference for data and documents across research and development (R&D) business processes.

Pratyusha Pallavi, head of regulatory product Management at ArisGlobal, said handling regulatory issues can be a formidable challenge for many life-science organizations.

Regulatory teams face many challenges, including keeping global teams aligned, managing growing regulatory complexity, and siloed information that slows the R&D process​,” Pallavi said. “LifeSphere Regulatory solves these challenges by providing an intuitive and flexible suite that’s focused on risk reduction, collaboration, and efficiency​.”

According to the company, LifeSphere Regulatory is built to provide efficiency through automation capabilities, as well as an approach that allows regulatory tasks to be handled in one simple interface. The platform reduces risk and stays up to date with the latest regulations via modern cloud architecture that delivers free upgrades and future-proof compliance. Notably, unlike other RIMS applications, LifeSphere Regulatory comes Identification of Medicinal Products (IDMP)-ready.

Giving key stakeholders across an organization access to the same documents and data reportedly helps keep teams around the world aligned. The company reports the LifeSphere Regulatory platform enables teams to work together without having to resort to time-resuming workarounds.

Learn more about LifeSphere Regulatory here​, and about LifeSphere EasyDocs​ here. 

DIA 2020 presentations

ArisGlobal will be presenting at two sessions during DIA 2020

  • Leveraging Automation in PV​, Monday June 15th at 10:15 am: Emmanuel Belabe, associate vice president of safety at ArisGlobal will walk attendees through a view of how organizations are approaching and implementing automation.
  • The Evolving Role of CTMS in Risk Management​, Tuesday June 16, 10:45 am: ArisGlobal’s senior director of clinical Sondra Pepe will explore how the CTMS footprint is evolving with the advent of a quality by design approach to clinical operations.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Planning Your First-In-Human Trial

Planning Your First-In-Human Trial

Altasciences | 15-Jul-2022 | Technical / White Paper

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug. A successfully conducted FIH trial provides...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 13-Jul-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us


View more